Enliven Therapeutics CMO Helen Collins sells $251k in shares By Investing.com - Investing.com Canada
Source: Investing.com Canada ·
Enliven Therapeutics CMO Helen Collins sells $251k in shares By Investing.com Investing.com Canada
BestAIBroker analysis
- Finance-aware sentiment: slightly negative (-0.30 on a -1 to +1 scale).
- Event classification: OTHER.
- Market importance score: 30/100, weighting entity relevance, source credibility, multi-outlet coverage and recency.
- Symbols referenced: ELVN.